Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2013

The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab
Authors: K. BENESOVA, K. FORSTEROVA, H. VOTAVOVA, V. CAMPR, J. STRITESKY, Z. VELENSKA, B. PROCHAZKA, R. PYTLIK, M. TRNENY
Neoplasma Vol.60, No.1, p.68-73, 2013
doi:10.4149/neo_2013_010
Price: free access
[View Abstract]


Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer
Authors: M. KASPRZYK, W. DYSZKIEWICZ, C. PIWKOWSKI, M. BRUDLO, B. GALECKI, P. GABRYEL, L. GASIOROWSKI
Neoplasma Vol.60, No.1, p.62-67, 2013
doi:10.4149/neo_2013_009
Price: free access
[View Abstract]


Altered Expression of ezrin, E-Cadherin and β-Catenin in Cervical Neoplasia
Authors: E. AUVINEN, O. CARPEN, T. KORPELA, M. RONTY, A. VAHERI, J. TARKKANEN
Neoplasma Vol.60, No.1, p.56-61, 2013
doi:10.4149/neo_2013_008
Price: free access
[View Abstract]


Rosiglitazone Shows Partial Oncostatic Effect in Rat Mammary Carcinogenesis
Authors: B. BOJKOVA, K. KAJO, M. GARAJOVA, P. KUBATKA, M. PEC, T. KISKOVA, P. ORENDAS, M. KASSAYOVA, M. KORPOVA, M. MIKLOSOVA
Neoplasma Vol.60, No.1, p.46-55, 2013
doi:10.4149/neo_2013_007
Price: free access
[View Abstract]


Targeting rictor inhibits mouse vascular tumor cell proliferation and invasion in vitro and tumor growth in vivo
Authors: N. N. ZHENG, X. D. DING, H. P. ZHANG
Neoplasma Vol.60, No.1, p.41-45, 2013
doi:10.4149/neo_2013_006
Price: free access
[View Abstract]


Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma
Authors: D. GUO, C. LI, Q. TENG, Z. SUN, Y. LI, C. ZHANG
Neoplasma Vol.60, No.1, p.33-40, 2013
doi:10.4149/neo_2013_005
Price: free access
[View Abstract]


Skin Rash as Useful Marker of Erlotinib Efficacy in NSCLC and Its Impact on Clinical Practice
Authors: O. FIALA, M. PESEK, J. FINEK, J. KREJCI, J. RICAR, Z. BORTLICEK, L. BENESOVA, M. MINARIK
Neoplasma Vol.60, No.1, p.26-32, 2013
doi:10.4149/neo_2013_004
Price: free access
[View Abstract]


Prognostic Analysis of Patients with Operable Gastric Cancer and Tolerability to Adjuvant Radio-Chemo-Therapy
Authors: M. Kucukoner, E. Arpaci, A. Isikdogan, M. Bilici, D. Uncu, B. Cetin, F. Dane, M. Inanc, A. S. Ekinci, A. Inal, K. Cayir, T. Yetisyigit, N. Ozdemir, M. A. Kaplan, S. Aksoy, N. Alkıs, S. B. Tekin, C. Eroglu, S. Turhal, S. Buyukberber
Neoplasma Vol.60, No.1, p.19-25, 2013
doi:10.4149/neo_2013_003
Price: free access
[View Abstract]


Serum biomarkers analyzed by LC-MS/MS as predictors for short outcome of non-small cell lung cancer patients treated with chemoradiotherapy
Authors: W. HUANG, X. DING, B. LI, M. FAN, T. ZHOU, H. SUN, Y. YI, J. ZHANG
Neoplasma Vol.60, No.1, p.11-18, 2013
doi:10.4149/neo_2013_002
Price: free access
[View Abstract]


Tumor microenvironment and the role of mesenchymal stromal cells
Authors: L. KUCEROVA, S. SKOLEKOVA
Neoplasma Vol.60, No.1, p.1-10, 2013
doi:10.4149/neo_2013_001
Price: free access
[View Abstract]





Display #  
Results 81 - 90 of 90

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.